Trial Profile
Comparison of the hypoglycemic effect of sitagliptin versus the combination of mitiglinide and voglibose in drug-naive Japanese patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Mitiglinide; Voglibose
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 30 Jul 2013 New trial record